Baseline immune signature scores of peripheral blood predict outcome to checkpoint inhibitor therapy in cancer patients

被引：0
|
作者：
Hattenhauer, S. T. [1 ]
Mispelbaum, R. [1 ]
Held, S. A. E. [1 ]
Marques, Palma L. [1 ]
Brossart, P. [1 ]
Heine, A. [1 ]
机构：
[1] Univ Hosp Bonn, Dept Oncol Hematol Immune Oncol & Rheumatol, Bonn, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1112
引用
下载
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [41] Immune profile analysis of peripheral blood and tumors of lung cancer patients treated with immune checkpoint inhibitors
    Ichiki, Yoshinobu
    Fukuyama, Takashi
    Ueno, Mari
    Kanasaki, Yoshiro
    Goto, Hidenori
    Takahashi, Mai
    Mikami, Shuji
    Kobayashi, Noritada
    Nakanishi, Kozo
    Hayashi, Shinichi
    Ishida, Tsuyoshi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 2192 - 2207
  • [42] Monocyte Subpopulations and myeloid Suppressor Cells in the peripheral Blood of Cancer Patients during Immune Checkpoint-inhibiting Therapy
    Peischl, C.
    Preusser, M.
    Berghoff, A. S.
    Fendl, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 229 - 230
  • [43] Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
    Roehl, Louisa
    Wellhausen, Jana
    Berszin, Michael
    Kruecken, Irene
    Zebralla, Veit
    Pirlich, Markus
    Wiegand, Susanne
    Dietz, Andreas
    Wald, Theresa
    Wichmann, Gunnar
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [44] Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis
    Wallwork, Rachel S.
    Kotzin, Jonathan J.
    Cappelli, Laura C.
    Mecoli, Christopher
    Bingham III, Clifton O.
    Wigley, Fredrick M.
    Wilson, Parker C.
    DiRenzo, Dana
    Shah, Ami A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
  • [45] Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer
    Chang, John Wen-Cheng
    Hsieh, Jia-Juan
    Tsai, Chih-Yu
    Chiu, Horng-Yih
    Lin, Yu-Feng
    Wu, Chiao-En
    Shen, Yung-Chi
    Hou, Ming-Mo
    Chang, Chieh-Ying
    Chen, Jian-An
    Chen, Chyi-Liang
    Chiu, Cheng-Tang
    Yeh, Yuan-Ming
    Chiu, Cheng-Hsun
    BIOMEDICAL JOURNAL, 2024, 47 (05)
  • [46] Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer A Systematic Review
    Asdourian, Maria S.
    Shah, Nishi
    Jacoby, Ted V.
    Reynolds, Kerry L.
    Chen, Steven T.
    JAMA DERMATOLOGY, 2022, 158 (08) : 933 - 941
  • [47] Quality of life in late-stage cancer patients on immune checkpoint inhibitor therapy
    Boyle, J.
    Ahmed, D.
    Galiauskas, D.
    Bird, D.
    ANNALS OF ONCOLOGY, 2022, 33 : S283 - S283
  • [48] Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings
    Wang, Gary X.
    Kurra, Vikram
    Gainor, Justin F.
    Sullivan, Ryan J.
    Flaherty, Keith T.
    Lee, Susanna I.
    Fintelmann, Florian J.
    RADIOGRAPHICS, 2017, 37 (07) : 2132 - 2144
  • [49] IMMUNE CHECKPOINT INHIBITOR ASSOCIATED VASCULITIS: A LIMITATION TO CANCER THERAPY
    Au, Marcus
    Faher, Anissa
    Htut, Ei Ei Phyu
    RHEUMATOLOGY, 2023, 62
  • [50] The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
    Wang, Chengdi
    Li, Jingwei
    Zhang, Qiran
    Wu, Jiayang
    Xiao, Yuxuan
    Song, Lujia
    Gong, Hanlin
    Li, Yalun
    BMC CANCER, 2021, 21 (01)
12345